Prior studies from Zhao et al. have noted the importance of fatty acid metabolism in ccRCC progress and focused on certain multiple fatty acid metabolic enzymes including CPT1A, HADHA, HADHB, and ACAT1 while no extra multiomics data or clinical treatment cohorts were incorporated [12]. The gene discussed is ACAT1; the disease is nonpapillary renal cell carcinoma.